Alfacell (ACEL) Selects TS Communications And Feinstein Kean Healthcare, Inc. For Comprehensive Integrated Communications
9/18/2006 12:18:43 PM
More...
|
Janssen Pharmaceutica Products, L.P. And Feinstein Kean Healthcare Release: RISPERDAL (risperidone) Shown To Rapidly Reduce Manic Symptoms Associated With Bipolar Disorder
10/19/2005 5:11:35 PM
More...
|
ANZACC: Scientists From Australia And New Zealand Discuss Stem Cell Research And Clinical Trials At 3rd Annual Conference In Cambridge, Massachusetts
10/19/2005 5:11:29 PM
More...
|
Feinstein Kean Healthcare Expands Creative Services To Meet Client Demand
10/19/2005 5:11:16 PM
More...
|
Janssen Pharmaceutica Products, L.P. Release: Risperdal Consta Improves Symptom Control In Many People With Schizophrenia
10/19/2005 5:11:12 PM
More...
|
Janssen Pharmaceutica Products, L.P. Release: Many Stabilized, Young Adults With Schizophrenia May Benefit From Early Treatment With Risperdal
10/19/2005 5:11:12 PM
More...
|
Feinstein Kean Healthcare, Inc.'s Rebranding Campaign For Nabi Biopharmaceuticals (NABI) Wins 2005 ReBrand 100(TM) Award
10/19/2005 5:09:07 PM
More...
|
Feinstein Kean Healthcare Release: New Office-Based Treatment For Prescription Drug And Heroin Addiction
10/19/2005 5:08:57 PM
More...
|